BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34528694)

  • 1. Abnormally elevated ubiquilin‑1 expression in breast cancer regulates metastasis and stemness via AKT signaling.
    Feng X; Cao A; Qin T; Zhang Q; Fan S; Wang B; Song B; Yu X; Li L
    Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34528694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of human non-small cell lung cancer cells.
    Shah PP; Lockwood WW; Saurabh K; Kurlawala Z; Shannon SP; Waigel S; Zacharias W; Beverly LJ
    Oncogene; 2015 Mar; 34(13):1709-17. PubMed ID: 24747970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
    Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
    EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation.
    Li B; Lu Y; Yu L; Han X; Wang H; Mao J; Shen J; Wang B; Tang J; Li C; Song B
    Chem Biol Interact; 2017 Nov; 277():33-42. PubMed ID: 28844858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATG4A promotes tumor metastasis by inducing the epithelial-mesenchymal transition and stem-like properties in gastric cells.
    Yang SW; Ping YF; Jiang YX; Luo X; Zhang X; Bian XW; Yu PW
    Oncotarget; 2016 Jun; 7(26):39279-39292. PubMed ID: 27276686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
    Qin T; Li B; Feng X; Fan S; Liu L; Liu D; Mao J; Lu Y; Yang J; Yu X; Zhang Q; Zhang J; Song B; Li M; Li L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):287. PubMed ID: 30482232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.
    Han M; Liu M; Wang Y; Chen X; Xu J; Sun Y; Zhao L; Qu H; Fan Y; Wu C
    PLoS One; 2012; 7(6):e39520. PubMed ID: 22761812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
    Xu JH; Wang Y; Xu D
    Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.
    Wang L; Tang C; Cao H; Li K; Pang X; Zhong L; Dang W; Tang H; Huang Y; Wei L; Su M; Chen T
    Cancer Biol Ther; 2015; 16(8):1220-30. PubMed ID: 26121010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PODXL2 maintains cellular stemness and promotes breast cancer development through the Rac1/Akt pathway.
    Lin YY; Wang CY; Phan NN; Chiao CC; Li CY; Sun Z; Hung JH; Chen YL; Yen MC; Weng TY; Hsu HP; Lai MD
    Int J Med Sci; 2020; 17(11):1639-1651. PubMed ID: 32669966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
    Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
    J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uev1A promotes breast cancer cell migration by up-regulating CT45A expression via the AKT pathway.
    Niu T; Wu Z; Xiao W
    BMC Cancer; 2021 Sep; 21(1):1012. PubMed ID: 34503444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Ubiquilin1 expression in invasive breast cancer.
    Wang Y; Lu J; Zhao X; Feng Y; Lv S; Mu Y; Wang D; Fu H; Chen Y; Li Y
    Cancer Biomark; 2015; 15(5):635-43. PubMed ID: 26406952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JARID2 promotes invasion and metastasis of hepatocellular carcinoma by facilitating epithelial-mesenchymal transition through PTEN/AKT signaling.
    Lei X; Xu JF; Chang RM; Fang F; Zuo CH; Yang LY
    Oncotarget; 2016 Jun; 7(26):40266-40284. PubMed ID: 27259236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma.
    Yang Z; Zhang C; Qi W; Cui Y; Xuan Y
    Exp Cell Res; 2018 Dec; 373(1-2):145-154. PubMed ID: 30321514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
    Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
    Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin‑3‑methyl ether suppresses human breast cancer stem cell formation by inhibiting the Notch1 and PI3K/Akt signaling pathways.
    Cao L; Yang Y; Ye Z; Lin B; Zeng J; Li C; Liang T; Zhou K; Li J
    Int J Mol Med; 2018 Sep; 42(3):1625-1636. PubMed ID: 29956731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.